---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000612"
form_type: "8-K/A"
ticker: "MRAI"
cik: "0001844392"
company_name: "Marpai, Inc."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:15:17.788107+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Marpai files Maestro Health financials; acquired co. net loss $29.3M in 2021

## Summary
- Maestro Health 2021 revenue $19.4M, net loss $29.3M; members' deficit $35.1M as of Dec 31, 2021.
- Unaudited nine-month 2022 financial statements included; acquisition closed Nov 1, 2022.
- Pro forma combined financials filed; Maestro Health reports going concern with AXA support through May 2023.
- Marpai acquired Maestro Health via membership interest purchase; no deal value disclosed in this filing.

## SEC filing metadata
- accession: 0000950170-23-000612
- form_type: 8-K/A
- ticker: MRAI
- cik: 0001844392
- company_name: Marpai, Inc.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/0000950170-23-000612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/mrai-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000612
- JSON: https://secwatch.observer/filing/0000950170-23-000612.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000612.txt

## Key facts
- M&A Transactions
  Marpai, Inc. completed an acquisition involving Maestro Health, LLC for Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., Seaview Re Holdings Inc., and AXA S.A. (closed 2022-11-01).
  - Action: acquisition
  - Counterparty: Maestro Health, LLC
  - Consideration: Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., Seaview Re Holdings Inc., and AXA S.A.
  - Closing: 2022-11-01
  source text: On November 1, 2022, Marpai, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Report”) to report the Company’s consummation of Maestro Health, LLC (“Maestro Health”), a Delaware limited liability company, pursuant to the terms of the Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation, and AXA S.A., a French société anonyme.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844392/000095017023000612/0000950170-23-000612-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.